ArticleJCO clinical cancer informatics2024

Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non-Small Cell Lung Cancer.

Chiharu Sako et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.